Drug
Csl889
Csl889: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| CSL889 NCT06699849 | Phase 2 | Sickle Cell Disease Vaso-occlusive Crisis |
Latest
No recent events.
Follow Csl889 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.